Table 4. Antimicrobial resistance by species of Campylobacter spp. identified in a multicenter retrospective study on vascular infections and endocarditis caused by Campylobacter spp., France*.
| Antimicrobial tested | MIC breakpoint, mg/L | No. (%) isolates |
||
|---|---|---|---|---|
| C. fetus | C. jejuni | Other Campylobacter spp. | ||
| Ampicillin | 16 | 1/44 (2.3) | 3/5 (60) | 1/2 (50) |
| Amoxicillin/clavulanate | 16 | 0/40 | 0/5 | 0/3 |
| Ciprofloxacin | 0.5 | 11/44 (25) | 3/5 (60) | 2/2 (100) |
| Erythromycin | 4 | 1/43 (2.3) | 0/5 | 0/2 |
| Tetracycline | 2 | 5/38 (13.2) | 4/5 (80) | 0/1 |
| Gentamicin†| 2 | 0/41 | 0/5 | 0/2 |
| Imipenem | 2 | 0/7 | Not tested | 0/1 |
*Strains susceptible to gentamicin were assumed to be susceptible to amikacin.